StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > $2 is the realistic target soon

<< Previous

Bullboard Posts

Next >>

Comment by Marcus358on Apr 11, 2021 7:58pm

60 Views

Post# 32975223

RE:$2 is the realistic target soon

wow keep on pumping for a $2 price...you can't even justified the catalyst for this to go up in that price. the bashers are just saying the truth....the history will judge SZ. the market is punishing SZ for not being truthful in all its dealing towards it shareholder. We can't anymore trust tripp on how he manage this company.........running this in the ground in just 1 week is a shameful history.